TGFB1 and pulmonary fibrosis: Finally, NCT03727802, a study with TRK-250, a nucleic acid compound that inhibits the progression of experimental pulmonary fibrosis by selectively suppressing gene expression of TGF-β1, is currently (October 2019) still recruiting.